Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Coegin Pharma

3.92 SEK

+3.16 %

Less than 1K followers

COEGIN

Nordic SME

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Coegin Pharma

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue0.10.1
EBITDA-4.8-6.4-20.3-4.9-3.2-3.3-6.1-17.4
EBIT-5.6-7.1-23.3-5.6-3.9-4.1-6.9-20.5
EBIT-%-8,575.0 %-25,888.6 %
Profit before taxes-5.7-7.0-23.8-5.6-3.9-4.1-6.9-20.5
Net income-5.7-7.0-23.8-5.6-3.9-4.1-6.9-20.5
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.